V. Grosso

Atherosclerosis and Rheumatoid Arthritis: More Than a Simple Association

Lorenzo Cavagna, Nicola Boffini, Giovanni Cagnotto et al. · Mediators of Inflammation · 2012 · 81 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.

M. Manara, Roberto Caporali, Ennio Giulio Favalli et al. · PubMed · 2017 · 28 citations

Medicine, Biostatistics, Pharmacotherapy +14

Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from the <scp>LORHEN</scp> registry

Ennio Giulio Favalli, L. Sinigaglia, Andrea Becciolini et al. · International Journal of Rheumatic Diseases · 2017 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +14